Personal information

Other IDs

Scopus Author ID: 57192238309

Activities

Collapse all

Employment (2)

Roche: Basel, CH

2022-04-01 to present | Scientist (PTDE-P)
Employment
Source: Self-asserted source
Marc Heitz

Roche: Basel, CH

2019-10-01 to 2022-03-31 | Post-Doc (PTDE-P)
Employment
Source: Self-asserted source
Marc Heitz

Education and qualifications (1)

University of Bern: Bern, Bern, CH

2014-02-03 to 2018-01-24 | PhD (Chemistry and biochemistry)
Education
Source: Self-asserted source
Marc Heitz

Works (11)

Enzymatic degradation pattern of polysorbate 20 impacts interfacial properties of monoclonal antibody formulations

European Journal of Pharmaceutics and Biopharmaceutics
2024-01 | Journal article
DOI: 10.1016/j.ejpb.2023.11.024
Contributors: Kathrin Gregoritza; Christos Theodorou; Marc Heitz; Tobias Graf; Oliver Germershaus; Manuel Gregoritza
Source: check_circle
Crossref

Lipophilic Peptide Dendrimers for Delivery of Splice-Switching Oligonucleotides

Pharmaceutics
2021-01-18 | Journal article
DOI: 10.3390/pharmaceutics13010116
Contributors: Haneen Daralnakhla; Osama Saher; Susanna Zamolo; Safa Bazaz; Jeremy P. Bost; Marc Heitz; Karin E. Lundin; Samir EL Andaloussi; Tamis Darbre; Jean-Louis Reymond et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Fluorescent Peptide Dendrimers for siRNA Transfection: Tracking pH Responsive Aggregation, siRNA Binding and Cell Penetration

Bioconjugate Chemistry
2020-05-18 | Journal article
DOI: 10.1021/acs.bioconjchem.0c00231
Part of ISSN: 1043-1802
Part of ISSN: 1520-4812
Source: Self-asserted source
Marc Heitz
grade
Preferred source (of 2)‎

Stereoselective pH Responsive Peptide Dendrimers for siRNA Transfection

Bioconjugate Chemistry
2019-08-21 | Journal article
DOI: 10.1021/acs.bioconjchem.9b00403
Contributors: Marc Heitz; Sacha Javor; Tamis Darbre; Jean-Louis Reymond
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Selectivity, efficacy and toxicity studies of UCCB01-144, a dimeric neuroprotective PSD-95 inhibitor

Neuropharmacology
2019-05 | Journal article
DOI: 10.1016/j.neuropharm.2019.02.035
Contributors: Anders Bach; Bettina H. Clausen; Lotte K. Kristensen; Maria G. Andersen; Ditte Gry Ellman; Pernille B.L. Hansen; Henrik Hasseldam; Marc Heitz; Dennis Özcelik; Ellie J. Tuck et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Lipidated Peptide Dendrimers Killing Multidrug Resistant Bacteria

2018 | Journal article
DOI: 10.1021/jacs.7b11037
EID:

2-s2.0-85040339215

Part of ISBN:

15205126 00027863
Source: Self-asserted source
Marc Heitz
grade
Preferred source (of 2)‎

Novel peptide-dendrimer/lipid/oligonucleotide ternary complexes for efficient cellular uptake and improved splice-switching activity

European Journal of Pharmaceutics and Biopharmaceutics
2018-11 | Journal article
DOI: 10.1016/j.ejpb.2018.09.002
Part of ISSN: 0939-6411
Source: Self-asserted source
Marc Heitz
grade
Preferred source (of 2)‎

Frontiers in Medicinal Chemistry 2017 in Bern, Switzerland

2017 | Journal article
DOI: 10.1002/cmdc.201700306
EID:

2-s2.0-85030266697

Part of ISBN:

18607187 18607179
Source: Self-asserted source
Marc Heitz
grade
Preferred source (of 2)‎

Peptide dendrimer–lipid conjugates as DNA and sirna transfection reagents: Role of charge distribution across generations

Chimia
2017 | Journal article
DOI: 10.2533/chimia.2017.220
EID:

2-s2.0-85020945138

Part of ISBN:

00094293
Contributors: Heitz, M.; Kwok, A.; Eggimann, G.A.; Hollfelder, F.; Darbre, T.; Reymond, J.-L.
Source: Self-asserted source
Marc Heitz via Scopus - Elsevier

Peptide Dendrimer–Lipid Conjugates as DNA and siRNA Transfection Reagents: Role of Charge Distribution Across Generations

2017 | Journal article
Source: Self-asserted source
Marc Heitz

Efficient Transfection of siRNA by Peptide Dendrimer-Lipid Conjugates

2016 | Journal article
DOI: 10.1002/cbic.201600485
EID:

2-s2.0-85002323761

Part of ISBN:

14397633 14394227
Source: Self-asserted source
Marc Heitz
grade
Preferred source (of 2)‎

Peer review (1 review for 1 publication/grant)

Review activity for ACS omega. (1)
How many people are using ORCID?